Samsung Bioepis Co., Ltd. vs. Alexion Pharmaceuticals, Inc. et al.

Explore the PTAB proceeding IPR2023-00933 filed by Samsung Bioepis Co., Ltd. on 2023-05-18. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00933

Filing Date

2023-05-18

Accorded Filing Date

2023-05-18

Institution Decision Date

2023-12-08

Last Modified Date

2024-09-04

Proceeding Type

IPR

Termination Date

2024-09-04

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Samsung Bioepis Co., Ltd.

Represented By

Rhyu, Michelleet al

Patent Owner / Respondent

Alexion Pharmaceuticals, Inc. et al.

Represented By

Flattmann, Geraldet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 15284015

Respondent Patent Number 9732149

External Links

Espacenet

Google Patents

Respondent Inventor Leonard BELL et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

61 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP

Customer Number 20306

Address 300 S. WACKER DRIVE, 32ND FLOOR, CHICAGO, IL, 60606, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
28399	Daniel Boehnen	312-913-0001
30130	Bradley Hulbert	312-913-0001
30243	Paul Berghoff	312-913-0001
32565	Grantland Drutchas	312-913-2121
32784	Steven Sarussi	312-913-0001
35285	Emily Miao	312-913-0001
35303	Kevin Noonan	312-913-0001
35818	Lawrence Aaronson	312-913-0001
39682	Patrick Gattari	312-913-0001
41269	Joshua Rich	312-913-0001
41962	Richard Machonkin	312-913-0001
42636	David Harper	312-913-0001
48701	Christopher Singer	2022204201
48710	Donald Zuhn	312-913-0001
50415	Dmitriy Vinarov	312-913-0001
50419	James Suggs	312-913-0001
50469	Joseph Herndon	312-913-0001
50967	Eric Moran	312-913-0001
51403	Jeffrey Anderson	312-913-0001
52087	Sherri Oslick	312-913-0001
56832	Matthew Ridsdale	312-913-0001
56898	Adam Faier	312-913-2123
57432	David Ciesielski	312-913-0001
57628	Jori Fuller	312-913-0001
58792	Nicole Reifman	312-913-0001
59054	John Conour	312-913-3317
59840	Allison Williams	312-526-1515
59916	Gavin O'Keefe	312-913-0001
60748	Isadora Bielsky	312-913-0001
62361	Michael Borella	312-913-0001
62900	Colin Wright	312-913-3385
66870	Christopher Scurry	312-913-3350
66926	Jason Kray	312-913-0001
67673	Jordan Pringle	312-913-0001
67838	Amir Shenouda	312-913-3359
69068	Aaron Gin	312-913-3360
69550	James Lovsin	312-913-0001
70335	Joshua Bosman	312-913-0001
70528	Manav Das	312-913-2117
70534	Alexander Georges	312-913-0001
71381	Chad Kamler	312-913-0001
71391	Daniel Pozdol	312-913-3303
73538	Benjamin Rellinger	312-913-3399
74547	Andrew Velzen	312-913-0001
74965	Mateusz Kulesza	312-913-3362
76021	Amma Addai	312-913-3323
76884	George Lyons Iii	312-913-3372
78192	Bryan Helwig	312-913-0001
79916	Megan Hanley	312-913-2350
79950	Jerry Lu	312-913-2011
80076	Alexandra Criner	312-913-2139
80110	My Chau Ta	312-913-0001
82034	Alexander Lu	312-913-2142
82477	Yuri Levin-Schwartz	312-913-0001
82718	Luke Koenigsknecht	312-913-0004
82720	Ronald Lucarelli	312-913-0001
82851	Alexa Dian	630-254-5113
82873	Christian Karpinski	312-913-2116
83005	Taylor Weilnau	312-913-2108
83223	Brandon Furdock	248-860-2510
83355	Kyle Planck	312-913-0006

Proceeding Documents

160

Termination Decision: Post-DI Settlement TERMINATE

2024-09-04 FILING PARTY: BOARD

Download

Joint Motion to Treat Settlement Agreement as Confidential MOTION

2024-08-30 FILING PARTY: PATENT OWNER

Download

Joint Motion to Terminate MOTION

2024-08-30 FILING PARTY: PATENT OWNER

Download

ORDER Setting Oral Argument ORDER

2024-08-26 FILING PARTY: BOARD

Download

Patent Owner's Request for Oral Argument OTHER

2024-08-07 FILING PARTY: PATENT OWNER

Download

Samsung Bioepis Co., Ltd. vs. Alexion Pharmaceuticals, Inc. et al.

Proceeding Overview

Parties & Counsel

Petitioner

Samsung Bioepis Co., Ltd.

Represented By

Patent Owner / Respondent

Alexion Pharmaceuticals, Inc. et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Termination Decision: Post-DI Settlement TERMINATE

Joint Motion to Treat Settlement Agreement as Confidential MOTION

Joint Motion to Terminate MOTION

ORDER Setting Oral Argument ORDER

Patent Owner's Request for Oral Argument OTHER

Petitioner's Request for Oral Hearing OTHER

Patent Owner's Updated Exhibit List NOTICE

Patent Owner's Sur-Reply OTHER

2108 - 2024.07.16 Jeffrey Ravetch Deposition Transcript (FULL) Exhibit

Notice of Deposition of J. Ravetch, M.D., Ph.D. NOTICE

SECOND MODIFIED SCHEDULING ORDER 37 C.F.R. § 42.5(c) ORDER

Exhibit 3005 Exhibit

Stipulation Modifying Due Dates OTHER

Petitioner's Reply ISO Petition REPLYTOOPP

Petitioner's Updated Exhibit List NOTICE

Deposition of Arturo Casadevall, January 24, 2020 Exhibit

Reply Declaration of Jeffrey V. Ravetch, M.D., Ph.D. Exhibit

Joint Stipulation Modifying Due Dates OTHER

2028 - Hill 2007 Exhibit

2035 - Shepherd Appx 2000 Exhibit

2038 - Haller 2008 Exhibit

2046 - 1997 INN Naming Guidelines Exhibit

2006 - Dmytrijuk Exhibit

2055 - Alexion Press Release 9-26-2006 Exhibit

2045 - 2007 USP Dictionary of USAN and Int'l Drug Names Exhibit

2051 - Foote 1992 Exhibit

2036 - Lo 2004 Exhibit

2105 - Declaration of A. Casadevall (for POR) FINAL [149] Exhibit

2049 - HemeOnc Today Exhibit

2075 - GenScript Final Report Exhibit

2054 - Alexion Press Release 9-20-2006 Exhibit

2034 - Hwang 2005 Exhibit

2033 - Kim 2005 Exhibit

2086 - Stebbings 2013 Exhibit

2029 - 1997 FDA pts to Consider MAbs Exhibit

2089 - Generium Elizaria Exhibit

2040 - Torres 2005 Exhibit

2090 - Samsung Biosimilar Pipeline Exhibit

2053 - Soliris Current Label (06-2019 Label) Exhibit

2091 - Harlowe and lane 1988 Exhibit

2037 - Welt 1997 Exhibit

2050 - Fatimah 2016 Exhibit

2047 - McClean 2005 Exhibit

2023 - CV Arturo Casadevall Exhibit

2039 - Torres 2007 PLOS Article Exhibit

2104 - 2024.02.23 Jeffrey Ravetch Deposition Transcript (FULL) Exhibit

2031 - Janeway Appx 2005 Exhibit

2052- Xiang 1995 Exhibit

2044 - Chadd 2001 Exhibit

2030 - Alexion Press Release 3-16-2007 Exhibit

2043 - Andersen 2004 Exhibit

Patent Owner Response RESPONSE

2014 - Greenspan Exhibit

2042 - Mathieu 2004 Exhibit

FIRST MODIFIED SCHEDULING ORDER ORDER

Ex 3004 Exhibit

Patent Owner's Notice of Deposition of Jeffrey V. Ravetch, M.D., Ph.D. NOTICE

Patent Owner's Notice of Deposition of Cindy Ippoliti, Pharm.D. NOTICE

Order: Scheduling Order ORDER

Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314 DECISION

US10703809 Exhibit

US10590189 Exhibit

Patent Owner's Sur-Reply to Petitioner's Reply to Preliminary Response OTHER

Petitioner's Reply to Patent Owner's Preliminary Response OTHER

Exhibit 3001 Exhibit